FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1591094 · Received January 26, 2010

Report

Report Number
2024168-2010-00117
Event Type
Injury
Date Received
January 26, 2010
Date of Event
June 30, 2009
Report Date
January 2, 2010
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B) (4). (B) (4). THE ADD'L RX XIENCE V 3.0 X 28 MM (PART# 1009541-28/LOT# 8053041) AND RX XIENCE V 3.5 X 08 MM (PART# 1009542-08/LOT# 8072861) STENTS ARE BEING FILED UNDER THE SAME MANUFACTURER NUMBER. IN THIS CASE, THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PT EFFECTS ARE KNOWN ADVERSE EVENTS LISTED IN THE RISK ASSESSMENT. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY-SURGICAL INTERVENTION. REPORTING RATIONALE: RESTENOSIS REQUIRING SURGICAL INTERVENTION. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED VIA A TRIAL THAT ON (B) (6) 2008, TWO 3.0 X 28 MM RX XIENCE V STENTS AND A 3.5 X 08 MM XIENCE V STENT WERE IMPLANTED IN THE PT. IN (B) (6) 2009, THE PT HAD CHEST PAIN AND WAS ADMITTED TO THE HOSPITAL. CARDIAC CATHETERIZATION AND BYPASS SURGERY WERE PERFORMED TO TREAT RESTENOSIS. NO ADD'L EVENT OR PT INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8043061

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| R| S RX XIENCE V 3.5 X 08 MM| (PART# 1009541-28/LOT# 8053041)| RX XIENCE V 3.0 X 28 MM| (PART# 1009542-08/LOT# 8072861)